¿Es el cinacalcet un tratamiento coste-efectivo en el hiperparatiroidismo secundario severo en pacientes en hemodiálisis?
Is cinacalcet a cost-effective treatment in severe secondary hyperparathyroidism in patients on hemodialysis?
Leído
12919
Vecesse ha leído el artículo
598
Total PDF
12321
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 27 | 0 | 27 |
| 2025 10 | 93 | 0 | 93 |
| 2025 9 | 85 | 0 | 85 |
| 2025 8 | 76 | 0 | 76 |
| 2025 7 | 79 | 0 | 79 |
| 2025 6 | 83 | 0 | 83 |
| 2025 5 | 135 | 0 | 135 |
| 2025 4 | 107 | 0 | 107 |
| 2025 3 | 151 | 0 | 151 |
| 2025 2 | 117 | 0 | 117 |
| 2025 1 | 120 | 0 | 120 |
| 2024 12 | 99 | 0 | 99 |
| 2024 11 | 75 | 0 | 75 |
| 2024 10 | 79 | 0 | 79 |
| 2024 9 | 120 | 0 | 120 |
| 2024 8 | 107 | 0 | 107 |
| 2024 7 | 106 | 0 | 106 |
| 2024 6 | 105 | 0 | 105 |
| 2024 5 | 90 | 0 | 90 |
| 2024 4 | 89 | 0 | 89 |
| 2024 3 | 63 | 1 | 64 |
| 2024 2 | 55 | 10 | 65 |
| 2024 1 | 81 | 8 | 89 |
| 2023 12 | 48 | 8 | 56 |
| 2023 11 | 46 | 9 | 55 |
| 2023 10 | 61 | 10 | 71 |
| 2023 9 | 58 | 7 | 65 |
| 2023 8 | 73 | 9 | 82 |
| 2023 7 | 83 | 9 | 92 |
| 2023 6 | 104 | 8 | 112 |
| 2023 5 | 90 | 9 | 99 |
| 2023 4 | 63 | 2 | 65 |
| 2023 3 | 67 | 1 | 68 |
| 2023 2 | 88 | 1 | 89 |
| 2022 1 | 73 | 0 | 73 |
| 2022 12 | 97 | 1 | 98 |
| 2022 11 | 76 | 1 | 77 |
| 2022 10 | 70 | 1 | 71 |
| 2022 9 | 63 | 0 | 63 |
| 2022 8 | 62 | 3 | 65 |
| 2022 7 | 69 | 0 | 69 |
| 2022 6 | 48 | 1 | 49 |
| 2022 5 | 73 | 3 | 76 |
| 2022 4 | 74 | 4 | 78 |
| 2022 3 | 61 | 0 | 61 |
| 2022 2 | 60 | 4 | 64 |
| 2021 1 | 51 | 2 | 53 |
| 2021 12 | 58 | 1 | 59 |
| 2021 11 | 57 | 1 | 58 |
| 2021 10 | 61 | 3 | 64 |
| 2021 9 | 50 | 0 | 50 |
| 2021 8 | 47 | 7 | 54 |
| 2021 7 | 43 | 0 | 43 |
| 2021 6 | 60 | 1 | 61 |
| 2021 5 | 60 | 28 | 88 |
| 2021 4 | 131 | 1 | 132 |
| 2021 3 | 97 | 0 | 97 |
| 2021 2 | 92 | 4 | 96 |
| 2020 1 | 49 | 2 | 51 |
| 2020 12 | 48 | 2 | 50 |
| 2020 11 | 57 | 2 | 59 |
| 2020 10 | 103 | 0 | 103 |
| 2020 9 | 62 | 2 | 64 |
| 2020 8 | 59 | 3 | 62 |
| 2020 7 | 56 | 1 | 57 |
| 2020 6 | 87 | 0 | 87 |
| 2020 5 | 82 | 3 | 85 |
| 2020 4 | 71 | 5 | 76 |
| 2020 3 | 46 | 12 | 58 |
| 2020 2 | 62 | 16 | 78 |
| 2020 1 | 66 | 7 | 73 |
| 2019 12 | 52 | 6 | 58 |
| 2019 11 | 75 | 5 | 80 |
| 2019 10 | 65 | 5 | 70 |
| 2019 9 | 47 | 1 | 48 |
| 2019 8 | 50 | 6 | 56 |
| 2019 7 | 45 | 9 | 54 |
| 2019 6 | 33 | 5 | 38 |
| 2019 5 | 38 | 6 | 44 |
| 2019 4 | 108 | 7 | 115 |
| 2019 3 | 48 | 4 | 52 |
| 2019 2 | 26 | 2 | 28 |
| 2019 1 | 43 | 3 | 46 |
| 2018 12 | 86 | 16 | 102 |
| 2018 11 | 99 | 17 | 116 |
| 2018 10 | 78 | 18 | 96 |
| 2018 9 | 73 | 12 | 85 |
| 2018 8 | 51 | 17 | 68 |
| 2018 7 | 54 | 14 | 68 |
| 2018 6 | 54 | 14 | 68 |
| 2018 5 | 47 | 13 | 60 |
| 2018 4 | 76 | 10 | 86 |
| 2018 3 | 56 | 12 | 68 |
| 2018 2 | 59 | 11 | 70 |
| 2018 1 | 42 | 7 | 49 |
| 2017 12 | 60 | 11 | 71 |
| 2017 11 | 35 | 6 | 41 |
| 2017 10 | 44 | 12 | 56 |
| 2017 9 | 41 | 11 | 52 |
| 2017 8 | 47 | 9 | 56 |
| 2017 7 | 40 | 5 | 45 |
| 2017 6 | 30 | 8 | 38 |
| 2017 5 | 41 | 21 | 62 |
| 2017 4 | 29 | 16 | 45 |
| 2017 3 | 28 | 4 | 32 |
| 2017 2 | 48 | 7 | 55 |
| 2016 1 | 27 | 8 | 35 |
| 2016 12 | 84 | 8 | 92 |
| 2016 11 | 90 | 13 | 103 |
| 2016 10 | 117 | 17 | 134 |
| 2016 9 | 126 | 9 | 135 |
| 2016 8 | 209 | 0 | 209 |
| 2016 7 | 164 | 0 | 164 |
| 2016 6 | 116 | 0 | 116 |
| 2016 5 | 126 | 0 | 126 |
| 2016 4 | 96 | 0 | 96 |
| 2016 3 | 85 | 0 | 85 |
| 2016 2 | 105 | 0 | 105 |
| 2015 1 | 103 | 0 | 103 |
| 2015 12 | 122 | 0 | 122 |
| 2015 11 | 105 | 0 | 105 |
| 2015 10 | 98 | 0 | 98 |
| 2015 9 | 80 | 0 | 80 |
| 2015 8 | 90 | 0 | 90 |
| 2015 7 | 77 | 0 | 77 |
| 2015 6 | 64 | 0 | 64 |
| 2015 5 | 103 | 0 | 103 |
| 2015 4 | 15 | 0 | 15 |
| 2015 2 | 2867 | 0 | 2867 |
Mostrar todo
